simpl.
ライフサイエンスeQMS 12項目

Dissolution Testing Program Checklist (USP <711>)

このチェックリストは英語版です。

Verifies that dissolution testing for oral and other dosage forms is properly developed, validated, qualified, and executed to assess drug release performance. Use to establish or audit a dissolution testing program.

USP <711>USP <1092>USP <711> Apparatus21 CFR 211.165

無料のPDFまたはWord・メールアドレスを入力してダウンロード。

Method Development and Validation

Establish a discriminating method.

  • Is the dissolution method developed to be discriminating for relevant formulation and process changes? *
  • Are media, volume, and sink conditions selected and justified for the drug solubility? *
  • Is the method validated for specificity, linearity, accuracy, and precision? *
  • Select the dissolution apparatus type used.

Apparatus Qualification

  • Is the dissolution apparatus mechanically qualified for parameters such as shaft wobble, vessel centering, and rotation speed? *
  • Is performance verification testing (PVT) or an enhanced mechanical calibration performed at the required frequency? *
  • Are media temperature (typically 37 +/- 0.5 C) and deaeration controlled? *

Acceptance Criteria and Testing

  • Are staged acceptance criteria (S1, S2, S3) applied for the tolerance (Q value)? *
  • Is the Q value and time point established and included in the release specification? *
  • Record the specified Q value (%) for the product.

Data Review and Investigation

  • Are dissolution results reviewed by the quality unit and any failures investigated? *
  • Are profile comparisons (e.g., f2 similarity factor) used to support changes where applicable?

Dissolution Testing Program Checklist (USP <711>)チェックリストの完全版をダウンロード

印刷しやすいPDF、または編集可能なWord文書で無料で入手できます。